Form 4: BeiGene Director Wang Xiaodong Sells American Depositary Shares

Director Wang Xiaodong sold American Depositary Shares of BeiGene, Ltd. on March 4, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 4, 2025, Wang Xiaodong, a director at BeiGene, Ltd., sold American Depositary Shares (ADS) of the company.
• The sales were executed in multiple transactions at varying prices, ranging from $251.15 to $257.43 per ADS.
• The total number of ADS sold was 7,345.
• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2024.
• Following the transactions, Wang Xiaodong continues to indirectly hold a significant number of Ordinary Shares through a family trust and Wang Investment LLC.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales by a company director. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions executed under a pre-existing plan.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency to the market regarding the transactions of company insiders, allowing investors to assess potential motivations and impacts on the stock.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but the existence of a pre-arranged trading plan mitigates concerns about insider information.

Key Dates